WELIREG 40 mg/1
belzutifan · TABLET, FILM COATED · Merck Sharp & Dohme LLC
No Recall History
Plain English
WELIREG is a tablet, film coated containing belzutifan at 40 mg/1, taken oral. Manufactured by Merck Sharp & Dohme LLC.
Key Facts
- Brand Name
- WELIREG
- Generic Name
- belzutifan
- NDC Code (Product)
0006-5331- Manufacturer
- Merck Sharp & Dohme LLC
- Strength
- 40 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA215383
- Drug Class
- Hypoxia-inducible Factor Inhibitor [EPC]
- Marketing Start
- 08/13/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is WELIREG used for?
WELIREG contains belzutifan. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is WELIREG a controlled substance?
WELIREG is not classified as a controlled substance by the DEA.
What is the generic name for WELIREG?
The generic name for WELIREG is belzutifan. There are no other listed brand versions of belzutifan.
What is the NDC code for WELIREG 40 mg/1?
The NDC (National Drug Code) for WELIREG 40 mg/1 is 0006-5331, listed by Merck Sharp & Dohme LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)